This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.
In this episode, I’ll discuss novel dosage forms that should not be crushed but look like they can be. Episode 575: Novel dosage forms that should not be crushed (but look like they can be) Subscribe on iTunes , Android , or Stitcher Two relatively new dosage form technologies are nanocrystals and amorphous solid dispersions.
Shout out to “Pharmacy John” who is a podcast listener and one of the study authors and recently brought this article to my attention. Secondary outcomes were the hospital length of stay, utilization of restraints, and discharge outcomes (to a facility when admitted from home) between dosage groups.
Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.
In this episode, I’ll discuss Paxlovid and other novel dosage forms that should not be crushed but look like they can be. Two relatively new dosage form technologies are nanocrystals and amorphous solid dispersions. Aprepitant, sirolimus, and certain forms of fenofibrate are examples of nanocrystal dosage forms.
There is still room for more research in this area, particularly with using different dosage schemes for midodrine – either increasing the dose per administration or giving it more frequently. The article in this episode is a selection from my Hospital Pharmacy Academys weekly literature digest.
In this episode, I’ll discuss Paxlovid and other novel dosage forms that should not be crushed but look like they can be. Two relatively new dosage form technologies are nanocrystals and amorphous solid dispersions. Aprepitant, sirolimus, and certain forms of fenofibrate are examples of nanocrystal dosage forms.
Episode 573: Ceiling dose of ketorolac for renal colic in the ED Subscribe on iTunes , Android , or Stitcher The analgesic ceiling dose of ketorolac is 10 mg, and this has been established in several articles going as far back as more than 30 years ago.
Shout out to “Pharmacy John” who is a podcast listener and one of the study authors and recently brought this article to my attention. Secondary outcomes were the hospital length of stay, utilization of restraints, and discharge outcomes (to a facility when admitted from home) between dosage groups.
A group of experts will present an encore abstract titled " Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using Real-World Data " at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20.
On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake.
HOPA has selected 4.0 CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. Additional information is available here. Subscribe Now!
1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release. December 21, 2004. Subscribe Now!
The investigators assessed a total of 90 patients who received talquetamab at a dosage of 0.8 mg/kg once every 2 weeks plus teclistamab at a dosage of 3.0 2 As a combination therapy, talquetamab and teclistamab show significant promise in the phase 1b/2 dose escalation and expansion in the RedirecTT-1 trial (NCT04586426).
This article focuses on the strong link between Hashimotos (elevated thyroid antibodies) and having OCD or developing OCD tendencies. You can learn more about our findings in this article. Please also refer to my recommendations in the linked article on the importance of gut health in Hashimotos. Coincidence? I think not!)
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content